menu
techminis

A naukri.com initiative

google-web-stories
Home

>

Bio News

>

Oxygen Dep...
source image

Bioengineer

1d

read

142

img
dot

Image Credit: Bioengineer

Oxygen Deprivation Drives Colon Cancer Progression

  • A study led by The University of Osaka reveals how oxygen deficiency within colon tumors drives their growth, challenging traditional beliefs about hypoxia in tumor progression.
  • Hypoxia within tumors induces a transformation in fibroblast cells, causing them to become pro-inflammatory and tumor-promoting in oxygen-depleted conditions near the tumor.
  • Transformed fibroblasts secrete growth-stimulating molecules like epiregulin and Wnt5a, promoting cancer cell proliferation and inhibiting angiogenesis to sustain hypoxia.
  • Research using murine models and human tissue samples confirms the consistency of fibroblast transformation and Wnt5a secretion across various disease states, suggesting potential therapeutic targets.
  • The study highlights the potential for targeting Wnt5a-secreting fibroblasts as a novel therapeutic approach in colon cancer and other conditions involving fibroblast activation and hypoxia.
  • The findings emphasize the need to reassess current anti-angiogenic therapies to avoid unintentionally accelerating cancer growth through hypoxia-induced fibroblast activation.
  • Understanding fibroblast behavior in hypoxic states could lead to novel treatment strategies not only in oncology but also in chronic inflammatory disorders like inflammatory bowel disease.
  • The translational potential of targeting Wnt5a-producing fibroblasts offers hope for disrupting the malignant microenvironment and improving colon cancer management.
  • The research methodology involved spatial mapping of oxygen levels, lineage tracing of fibroblast subpopulations, and gene expression analyses to establish the link between hypoxia and fibroblast-mediated tumor promotion.
  • This innovative study exemplifies the importance of translational research in bridging fundamental discoveries with clinical relevance, potentially accelerating the development of fibroblast-targeted therapies.

Read Full Article

like

8 Likes

For uninterrupted reading, download the app